Introduction
The prevalence of epilepsy among patients with cerebral calcification is a feature of patients with coeliac disease is disputed; some studies have shown both epilepsy and coeliac disease attending this an increased prevalence,1,2 while others have not. 3 hospital. The prevalence of coeliac disease, determined by antibody screening, among patients with epilepsy has been little studied.4
Methods
The existence of a specific syndrome of coeliac disease, epileptic seizures and intracranial calcifica-
Part 1 tion was proposed by Sammaritano and colleagues
Patients attending the Seizure Clinic of Cork in 1988,5 and was confirmed in several subsequent University Hospital who were able to give informed series.6-9 In the largest,6 5/12 patients with coeliac consent were invited to undergo screening for coeliac disease and epilepsy had cerebral calcification and, disease; 177 were recruited. Seizure type was classiconversely, of 31 patients with epilepsy and cerebral fied according to the scheme of the International calcification, 24 had coeliac disease. Nearly all League against Epilepsy,10 in which epilepsies are reported cases have been from Italy, and the prevaldescribed as generalized or as partial or focal. ence in other ethnic groups is uncertain.
Epilepsies may also be classified by aetiology: in The purposes of this study, therefore, were (i) to idiopathic epilepsy, there is no underlying cause assess the prevalence of coeliac disease in patients other than a possible hereditary disposition; symptoattending the Seizure Clinic of Cork University Hospital, and (ii) to determine whether radiological matic epilepsies and syndromes are the consequence of a known or suspected disorder of the central deficiency anaemia. Patient 4 was asymptomatic. All four patients had a low duodenal biopsy per gastronervous system; and cryptogenic epilepsies are presumed to be symptomatic, but the aetiology is not scope. Histological findings in each case were typical of coeliac disease (Table 1) . Therefore, the frequency known. A control group of 488 consecutive patients attending an ante-natal clinic were also screened for of coeliac disease among this sample of epilepsy patients is 1 in 44; in patients with epilepsy of coeliac disease. Measurement of IgA anti-endomysial antibody by indirect immunofluorescence using secundetermined cause (idiopathic or cryptogenic), the frequency of coeliac disease is 1 in 37. tions of human umbilical cord was used to screen for coeliac disease. Each patient gave informed
The mean age of the 488 control patients was 27.7 years (range: 14-48 years). Two patients tested consent. The study was approved by the Ethics Committee of Cork University Hospital.
positive for endomysial antibody (1 in 244).
Part 2 Part 2
A total of 16 patients (6 male, 10 female) with both The hospital records of all patients attending the epilepsy and coeliac disease, who had attended or gastroenterology clinic of Cork University Hospital were attending Cork University Hospital, were identiover a one-year period with a diagnosis of both fied. Four patients were identified from the screening epilepsy and coeliac disease were reviewed. Also, study (patients 1-4, Table 2 ), five from the gastroenthe computerized national Hospital In-Patient terology clinic (patients 5-9) and seven from the Enquiry (HIPE) database from 1982 to 1996 was HIPE database (patients 10-16). In seven patients, searched for patients from Cork University Hospital the diagnosis of epilepsy was made before that of with both these diagnoses. Seizure classification was coeliac disease, in seven patients, coeliac disease as above.10 Patients were invited to undergo cranial was diagnosed first, and in two patients, the two computerized tomographic (CT) scanning if they had conditions were diagnosed at about the same time. not had the procedure in the previous 2 years. All
The median age of detection of coeliac disease was CT scans were assessed by a consultant neuroradiolo-32 years (range <1-79 years), and of epilepsy, 20 gist (DQR). Three patients were deceased; the most years (<1-67 years). Five patients had onset of recent CT scans of these patients were reviewed. epilepsy during childhood. Seizure type is documented in Table 2 . Six patients continued to have seizures, and seven patients had been seizure-free for at least one year; three patients were deceased.
Results
One patient's CT scan showed lacunar infarcts, and
Part 1
three showed generalized cerebral atrophy. Twelve patients had a normal scan appearance. Serum samples were obtained from 177 out-patients Three patients are deceased (patients 14-16, Table  ( 80 male, 97 female). Mean age was 36 years (range 2). Patient 14, with known coeliac disease, presented 14-80 years), and median age of onset of epilepsy with simple partial seizures with motor signs was 14 years (range <1-63 years). Of the 177 ( Jacksonian epilepsy) and was found to have nonpatients recruited, 38% had generalized tonic-clonic Hodgkin's lymphoma, a recognized complication of seizures, 28% complex partial, 10% complex partial coeliac disease. Patient 15 developed epilepsy and with secondary generalization and 9% had generalmultiple sclerosis 3 years after diagnosis of coeliac ized myoclonic epilepsy. Seventy-seven patients disease. Patient 16 developed signs of dementia at (44% of total) had idiopathic seizures, 71 (40%) had age 60 years; at age 62, she presented with dermatitis cryptogenic seizures and 29 (16%) had symptoherpetiformis, and jejunal biopsy showed sub-total matic seizures.
villous atrophy. During her last year of life, she had Of 177 patients screened, four female patients recurrent grand mal epileptic seizures. tested positive for endomysial antibody (Table 1; patients 1-4, Table 2 ). In patient 1, coeliac disease had been diagnosed in childhood, but she had been Discussion non-compliant with gluten restriction since adolesence. The other three patients had not been suspected Coeliac disease and epilepsy of having coeliac disease at the time of screening. However, patient 2, in the interim between venesecIn 1966, Cooke and Smith described 'unexplained attacks of unconsciousness' in five patients with tion and receipt of the screening results, complained of loose stools and abdominal bloating, and investicoeliac disease.11 Chapman et al. reported a prevalence of epilepsy among patients with coeliac disease gations revealed coeliac disease. Patient 3 had no gastrointestinal symptoms, but had an occult iron of 5.5%,1 and Holmes described a 3.5% prevalence.2 The mechanism of the association is unknown and any suggestions are speculative. Coeliac disease coeliac disease with absent, mild or atypical features are unrecognized, and previous studies examining is an immunologically-mediated condition related to intolerance to dietary gluten. Many immunological patients with diagnosed coeliac disease may not be representative. The prevalence of coeliac disease abnormalities have been described in patients with epilepsy.17 Epilepsy occurs in immune-mediated conamong epilepsy patients, rather than the converse, may provide a more rigorous assessment of the ditions such as SLE, IgA deficiency and myasthenia gravis more often than would be expected by association between the two conditions. With the advent of reliable tests, it is now possible to screen chance.17,18 A number of immunoglobulin abnormalities have been described in epilepsy patients, in for coeliac disease with a high degree of accuracy; serum IgA endomysial antibody is considered the part related to anti-convulsant therapy,19 and epilepsy patients have a high prevalence of antinuclear and most sensitive and specific screening test available.12 Only one study has used sensitive antibody screening anticardiolipin antibodies.20 Immunoglobulin infusion is of proven benefit in some patients with methods to determine the prevalence of coeliac disease among patients with epilepsy.4 Fois et al.
epilepsy, particularly in children.21 Epilepsy in a subset of patients may, therefore, be the result of an reported a frequency of coeliac disease of 1 in 87 among patients attending an Italian paediatric epiimmune process, and the association between coeliac disease and epilepsy may be a reflection of the lepsy clinic.4 The results of the present study indicating a frequency of coeliac disease of 1 in 44 in the tendency of immunologically-mediated conditions to occur together. Neurological syndromes other than total group, and of 1 in 37 in patients with epilepsy of undetermined cause, suggest a significant associepilepsy may also be associated with coeliac disease.22 A suggested mechanism is that the antibodies ation between the two conditions.
In contrast, in the control group of 488 women associated with coeliac disease may be themselves neurotoxic or, alternatively, may be a marker for a attending an ante-natal clinic, only two serum samples were positive for endomysial antibody. The neurotoxic immunological process.22 A high index of suspicion for coeliac disease control group used has a number of shortcomings. It is not comparable to the epilepsy patient group in should exist in patients with epilepsy. Any patient with epilepsy with gastrointestinal or constitutional age or in gender distribution. In the patients with positive sera, coeliac disease was not confirmed by symptoms, no matter how mild or non-specific, or with any evidence of malabsorption, should be biopsy. Individuals with untreated coeliac disease have an increased incidence of infertility and of screened for coeliac disease. Untreated coeliac disease may account for poor seizure control, through spontaneous abortion,13,14 and may be underrepresented in a group of pregnant females. Many impaired drug absorption and possibly through occult malabsorption of vitamins and nutrients. Low serum immunologically-mediated conditions undergo remission during pregnancy, although this has not folic acid23 and vitamin D24 concentrations should not be automatically attributed to anti-convulsant been demonstrated for coeliac disease. A number of other studies have examined the prevalence of coeltherapy. There are suggestions that a gluten-free diet may have a beneficial effect on seizure control.6,25 iac disease in the general population. A large study from Italy suggested a figure of 1 in 300. 15 The sole
In addition, the institution of a gluten-free diet, even in asymptomatic patients without apparent conpopulation-based study from Ireland suggests a prevalence of coeliac disease of the order of 1 in 150. 16 sequences of coeliac disease is worthwhile. An increased risk of gastrointestinal malignancies, parThe prevalence figures obtained in patients with epilepsy in this study strongly indicate that coeliac ticularly small-bowel lymphoma,26 of osteoporosis,27 gnosed during childhood, and was apparent before cranial calcification appears to be relatively common 
